Search by Drug Name or NDC
NDC 00135-0300-02 ABREVA 100 mg/g Details
ABREVA 100 mg/g
ABREVA is a TOPICAL CREAM in the HUMAN OTC DRUG category. It is labeled and distributed by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. The primary component is DOCOSANOL.
Product Information
| NDC | 00135-0300 |
|---|---|
| Product ID | 0135-0300_4dda4911-3030-4b69-acc3-fb231b5f2e66 |
| Associated GPIs | |
| GCN Sequence Number | 047524 |
| GCN Sequence Number Description | docosanol CREAM (G) 10 % TOPICAL |
| HIC3 | Q5V |
| HIC3 Description | TOPICAL ANTIVIRALS |
| GCN | 12866 |
| HICL Sequence Number | 021956 |
| HICL Sequence Number Description | DOCOSANOL |
| Brand/Generic | Generic |
| Proprietary Name | ABREVA |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | docosanol |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | CREAM |
| Route | TOPICAL |
| Active Ingredient Strength | 100 |
| Active Ingredient Units | mg/g |
| Substance Name | DOCOSANOL |
| Labeler Name | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA208754 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00135-0300-02 (00135030002)
| NDC Package Code | 0135-0300-02 |
|---|---|
| Billing NDC | 00135030002 |
| Package | 2 TUBE in 1 PACKAGE (0135-0300-02) / 2 g in 1 TUBE |
| Marketing Start Date | 2022-04-25 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |